Sodium Citrate Drink: The In Situ Alkalizing Urinary pH Modulator

Let's dive right into the Recipe first and Details will follow later.

Recipe (For approximately 200 ml finished drink, 1 individual)

· Citric acid (anhydrous crystalline powder): 3 grams

· Sodium bicarbonate (baking soda, food grade): 4 grams

· Lemon juice (freshly squeezed): 5 ml

· Water (filtered, room temperature): 200 ml

Preparation Procedure

Step 1: Select a clear glass tumbler with a capacity in excess of 300 ml or better still use a 500 ml vessel. The reaction between citric acid and sodium bicarbonate produces carbon dioxide gas (CO₂) that will cause vigorous effervescence and foaming. A vessel that is too small will overflow.

Step 2: Add 3 grams of citric acid to 200 ml of filtered room temperature water. Stir well until the citric acid is fully dissolved. The solution will be clear and acidic, with a pH of approximately 2.5 to 3.0.

Step 3: Add the sodium bicarbonate powder slowly and in portions. Do not dump all 4 grams at once. Add approximately 0.5 to 1 gram at a time, waiting for the vigorous effervescence to subside before adding the next portion. The reaction is:

H₃C₆H₅O₇ (citric acid) + 3 NaHCO₃ (sodium bicarbonate) → Na₃C₆H₅O₇ (trisodium citrate) + 3 CO₂ (gas) + 3 H₂O (water)

The bubbling and fizzing indicate the release of carbon dioxide. This gas is the reason the mixture must be prepared in a large vessel. If the effervescence threatens to overflow, pause and allow the foam to subside before continuing.

Step 4: After all 4 grams of sodium bicarbonate have been added and the effervescence has completely subsided (approximately 30 to 60 seconds after the final addition), add 5 ml of freshly squeezed lemon juice. Stir well and drink immediately.

Step 5: Do not delay drinking after the reaction is complete. The solution is stable but the carbon dioxide that has been driven off will not return, and the drink is most palatable when consumed fresh.

Dosage: 200 ml one to three times daily, ideally between meals or upon waking. For urinary tract infection related irritation, the drink is most effective when taken every 6 to 8 hours to maintain sustained urinary alkalinization.

---

Now for the details:

This is not a simple soda water. It is a precision in situ neutralization formulation that converts citric acid and sodium bicarbonate into sodium citrate, a potent urinary alkalinizing agent, through an acid base reaction performed immediately before consumption. Unlike commercially available sodium citrate tablets or solutions that are manufactured through energy intensive drying and crystallization processes, this formulation generates the compound fresh in solution, preserving its full hydration sphere and ensuring complete conversion without the need for preservatives or stabilizers.

Every ingredient has been selected for a specific biochemical role. The citric acid provides the tricarboxylic acid backbone. The sodium bicarbonate provides the base required to neutralize the three carboxylic acid groups of citric acid. The lemon juice adds additional citrate and provides a pleasant citrus flavor that masks the salty taste of the final solution. The result is a drink that delivers approximately 4,000 mg of trisodium citrate per serving, containing approximately 1,080 mg of elemental sodium.

This formulation targets two primary clinical applications. The first is systemic alkalinization for metabolic acidosis, including mild to moderate acidosis from chronic kidney disease, renal tubular acidosis, or chronic diarrhea. The second is urinary alkalinization for relief of dysuria (painful urination) associated with urinary tract infections. Alkaline urine (pH above 7.0) reduces the irritation of the inflamed urethral and bladder mucosa, providing symptomatic relief while antibiotics address the underlying infection. Sodium citrate also reduces urinary calcium excretion, making this formulation useful for individuals with calcium oxalate or calcium phosphate kidney stones.

The in situ preparation method ensures that the trisodium citrate is consumed in its fully reacted, fully hydrated form. Commercial sodium citrate tablets often contain unreacted citric acid or sodium bicarbonate that must dissolve and react in the stomach. This in situ preparation completes the reaction before ingestion, eliminating gastric gas production and ensuring predictable alkalizing activity.

---

In Depth List of Bioactive and Beneficial Molecules

This formulation delivers a precise molecular complex. Below is the estimated quantity per 200 ml serving.

Trisodium Citrate (formed in situ):

· Trisodium citrate (Na₃C₆H₅O₇): approximately 4,000 to 4,100 mg

· Citrate anion (C₆H₅O₇³⁻): approximately 2,930 to 3,000 mg

· Elemental sodium (incorporated into trisodium citrate): approximately 1,070 to 1,090 mg

Lemon Juice Additions:

· Native citric acid: approximately 225 mg (from 5 ml lemon juice)

· Native ascorbic acid: approximately 2 to 3 mg

· Flavonoids (hesperidin, eriocitrin): approximately 1 to 2 mg

Reaction Byproducts:

· Carbon dioxide (gaseous, driven off): approximately 2,100 mg (not present in final drink)

Total Citrate Per Serving:

· From citric acid (3 grams converted to trisodium citrate): approximately 2,930 mg citrate equivalent

· From lemon juice (225 mg citric acid): approximately 210 mg citrate equivalent

· Total citrate: approximately 3,140 mg

Total Sodium Per Serving:

· From sodium bicarbonate (4 grams, containing 1,095 mg elemental sodium at 27.38 percent sodium by weight)

· Elemental sodium in trisodium citrate product: approximately 1,070 to 1,090 mg

· Sodium as a percentage of trisodium citrate: 26.7 percent

Electrolyte Profile:

· Sodium: 1,070 to 1,090 mg (46.5 to 47.4 mEq, assuming atomic weight 23.0)

· Citrate: approximately 3,140 mg (16.4 mEq, assuming trivalent anion with equivalent weight of 192)

Total Alkalizing Capacity:

· Measured as bicarbonate equivalent: approximately 45 to 50 mEq per serving

---

Analysis of the Benefits Based on Its Nutraceutical Profile

When you examine this formulation through the lens of precision nutrition science, several powerful therapeutic themes emerge.

1. The In Situ Neutralization Chemistry: Why Fresh Preparation Prevents Gastric Gas

The preparation procedure is not merely a mixing instruction. It is a controlled chemical synthesis performed in a glass tumbler. Citric acid is a triprotic acid with three carboxylic acid groups. Sodium bicarbonate is a monoprotic base. The complete neutralization reaction requires three molecules of sodium bicarbonate for every one molecule of citric acid.

The stoichiometry is as follows. Citric acid has a molecular weight of 192.1. Three molecules of sodium bicarbonate have a combined molecular weight of 3 multiplied by 84.0 equals 252.0. The ratio by mass of sodium bicarbonate to citric acid for complete neutralization is 252.0 divided by 192.1 equals approximately 1.312. The specified quantities of 3 grams citric acid and 4 grams sodium bicarbonate give a ratio of 4 divided by 3 equals 1.333, which is within 1.6 percent of the stoichiometric ratio. The slight excess of sodium bicarbonate (approximately 0.064 grams or 64 mg) ensures complete neutralization of all citric acid.

If this reaction were performed in the stomach by ingesting the dry powders separately, the carbon dioxide gas would be released in the gastric lumen, causing belching, bloating, and abdominal distension. By performing the reaction in the glass before drinking, the carbon dioxide is driven off into the atmosphere rather than into the stomach. The individual experiences no gas related discomfort. The degassed solution contains only the sodium citrate product, not the precursors.

2. Urinary Alkalinization for UTI Symptom Relief

The primary mechanism by which sodium citrate relieves urinary tract infection related irritation is urinary pH elevation. Normal urine pH ranges from 4.5 to 8.0, with an average of approximately 6.0. Acidic urine (pH below 5.5) is particularly irritating to inflamed urethral and bladder mucosa. Sodium citrate is metabolized to bicarbonate in the liver. The bicarbonate is excreted in the urine, raising the urine pH.

At a urine pH of 7.0 to 7.5, the solubility of uric acid increases dramatically, reducing the risk of uric acid crystal formation. More importantly for UTI symptoms, the alkaline environment is less irritating to the inflamed mucosa. Patients with acute cystitis often report significant reduction in dysuria, frequency, and urgency within 30 to 60 minutes of consuming a sodium citrate drink, well before antibiotics have had time to eradicate the bacterial infection.

The duration of the alkalinizing effect is approximately 3 to 4 hours after a single dose. For continuous symptom relief, the drink should be taken every 6 to 8 hours. The effect is purely symptomatic and does not treat the underlying bacterial infection. Antibiotics remain the definitive treatment for UTI.

3. Metabolic Acidosis Correction in Chronic Kidney Disease

Individuals with chronic kidney disease, particularly stage 3b, 4, and 5, often develop metabolic acidosis due to impaired renal excretion of acid. The normal kidneys excrete approximately 40 to 80 mEq of acid daily. When the glomerular filtration rate falls below 40 ml per minute, acid excretion becomes impaired, and metabolic acidosis develops.

Metabolic acidosis in chronic kidney disease has multiple adverse effects. It accelerates the progression of kidney disease by activating the alternative complement pathway and increasing tubulointerstitial fibrosis. It causes muscle wasting by increasing protein catabolism and activating the ubiquitin proteasome pathway. It causes bone demineralization by leaching calcium and phosphate from bone to buffer the excess acid. It causes fatigue, anorexia, and nausea.

Oral sodium citrate is the standard treatment for metabolic acidosis in chronic kidney disease when the serum bicarbonate falls below 22 mEq per liter. The dose typically ranges from 0.5 to 1.0 mEq of base per kilogram of body weight per day. This formulation provides approximately 45 to 50 mEq of base per serving, which is an appropriate dose for a 50 to 100 kg individual. For patients on sodium restricted diets, the high sodium content (1,070 to 1,090 mg per serving) may be problematic, and sodium free alkalinizing agents (calcium citrate or potassium citrate) should be used instead.

4. The Citrate Calcium Binding Mechanism

Citrate is a potent chelator of calcium ions. In the urine, citrate binds to calcium, forming a soluble calcium citrate complex that is excreted without crystallizing. This is the mechanism by which citrate reduces the risk of calcium oxalate and calcium phosphate kidney stones.

For individuals with a history of calcium oxalate stones, hypocitraturia (low urinary citrate excretion) is a common finding. Oral citrate supplementation increases urinary citrate excretion, restoring the protective effect. The dose required for stone prevention is typically 30 to 60 mEq of citrate daily. This formulation provides approximately 16.4 mEq of citrate per serving. Two servings per day would provide 32.8 mEq of citrate, which is within the therapeutic range for hypocitraturia.

5. The Sodium Load and Blood Pressure Considerations

The sodium content of this formulation is substantial. Four grams of sodium bicarbonate contains approximately 1,095 mg of elemental sodium. This is converted to trisodium citrate, which contains approximately 1,070 to 1,090 mg of elemental sodium. This is 46.5 to 47.4 percent of the American Heart Association's recommended daily sodium limit of 2,300 mg and 71 to 73 percent of the stricter limit of 1,500 mg for individuals with hypertension.

For individuals with normal blood pressure and normal kidney function, this sodium load is generally safe when consumed intermittently for UTI symptom relief (one to three days). For individuals with hypertension, heart failure, or chronic kidney disease, this sodium load is potentially dangerous. Such individuals should not use this formulation without physician guidance. Potassium citrate is a sodium free alternative for individuals who require citrate but must restrict sodium.

For individuals with normal kidney function, the acute sodium load from a single serving increases plasma volume transiently, which can be detected as a small weight gain. The kidneys excrete the excess sodium over the following 6 to 12 hours, provided hydration is adequate. There is no evidence that intermittent sodium citrate use for UTI symptoms causes long term blood pressure elevation.

6. The Lemon Juice Flavor Masking and Extra Citrate

The addition of 5 ml of lemon juice after the reaction is complete serves two functions. First, it masks the salty and slightly metallic taste of the sodium citrate solution. Trisodium citrate has a characteristic taste that many individuals find unpleasant. Lemon juice provides a sharp, acidic, citrus flavor that covers the saltiness.

Second, the lemon juice adds approximately 225 mg of native citric acid, which is not neutralized by sodium bicarbonate because it is added after the reaction is complete. This residual citric acid lowers the final pH of the drink slightly, making it more palatable. The citric acid is rapidly metabolized after ingestion and contributes to the alkalizing effect as well, as citrate is citrate regardless of whether it was added as the free acid or the sodium salt.

The lemon juice also provides a small amount of ascorbic acid (2 to 3 mg) and flavonoids (hesperidin, eriocitrin). These are present in negligible quantities relative to the therapeutic dose of sodium citrate and do not contribute significantly to the clinical effect.

7. Renal Tubular Acidosis: A Special Indication

Renal tubular acidosis is a condition in which the kidneys fail to acidify the urine appropriately, leading to a normal anion gap metabolic acidosis. There are several types. Distal renal tubular acidosis (type 1) is characterized by impaired acid secretion in the collecting duct. Proximal renal tubular acidosis (type 2) is characterized by impaired bicarbonate reabsorption in the proximal tubule.

Oral alkali therapy is the mainstay of treatment for both types. Sodium citrate is preferred over sodium bicarbonate for several reasons. Citrate is metabolized to bicarbonate, providing the base. Citrate also increases urinary calcium excretion to a lesser extent than bicarbonate, making it safer for individuals at risk of nephrocalcinosis. Citrate's calcium binding property reduces the risk of stone formation.

The dose required for renal tubular acidosis is typically 1 to 3 mEq of base per kilogram of body weight per day. This formulation provides 45 to 50 mEq per serving. A 70 kg individual would require approximately 70 to 210 mEq of base daily, which would be one to four servings of this drink.

8. The Carbon Dioxide Loss and Palatability

The vigorous effervescence that occurs when sodium bicarbonate is added to the citric acid solution is carbon dioxide gas. This gas is a byproduct of the neutralization reaction. Approximately 2,100 mg of CO₂ is produced from the reaction of 3 grams citric acid and 4 grams sodium bicarbonate. All of this gas is driven off during preparation.

The loss of carbon dioxide has two effects. First, it makes the drink flat rather than carbonated. Some individuals prefer carbonated beverages and may find the flatness unappealing. However, carbonation would not be retained because the reaction is complete before drinking. Second, the loss of CO₂ means the drink does not cause gastric distension or belching, which is the primary advantage of preparing the drink in the glass rather than ingesting the powders separately.

If a carbonated version is desired, the sodium bicarbonate can be added to the water first, followed by the citric acid. This order of addition produces the same reaction but the carbon dioxide is retained in solution because the reaction occurs more slowly. However, the effervescence will continue in the glass and the drink will be carbonated when consumed. This is a matter of personal preference and does not affect the therapeutic activity.

9. The Timing of Lemon Juice Addition

The instruction to add lemon juice after the reaction between citric acid and sodium bicarbonate is complete is important. If lemon juice is added before the sodium bicarbonate, the citric acid from the lemon juice will also react with the sodium bicarbonate, consuming some of the base that is intended to neutralize the powdered citric acid. This would result in incomplete neutralization of the powdered citric acid and a lower yield of trisodium citrate.

If lemon juice is added after the reaction is complete, the native citric acid in the lemon juice remains unreacted. This is acceptable because the amount is small (225 mg of citric acid, requiring 225 multiplied by 1.312 equals approximately 295 mg of sodium bicarbonate for complete neutralization). The sodium bicarbonate is already nearly exhausted by the reaction with the 3 grams of powdered citric acid. The unreacted citric acid from the lemon juice is negligible and does not affect the net alkalinizing capacity.

10. The Urinary pH Monitoring Parameter

For individuals using this formulation for UTI symptom relief or metabolic acidosis management, monitoring urinary pH is a useful way to confirm efficacy. Urinary pH test strips are inexpensive and readily available. The target urinary pH for UTI symptom relief is 7.0 to 7.5. The target for metabolic acidosis management is normalization of serum bicarbonate, but urinary pH can be used as a surrogate marker.

A single serving of this drink typically raises urinary pH by 1.0 to 1.5 units within 2 to 4 hours, depending on baseline urine pH, hydration status, and kidney function. If urinary pH remains below 6.5 two hours after consumption, a second serving may be required. If urinary pH rises above 8.0, the dose is excessive and the interval between doses should be increased.

Urinary pH should be measured on a fresh urine sample, not on urine that has been sitting at room temperature, as bacterial metabolism can raise pH over time. First morning urine typically has the lowest pH and is not representative of the post dose alkalinization. For monitoring the effect of the drink, measure pH 2 to 4 hours after consumption.

---

Important Considerations

Medication Interactions: Sodium citrate can increase the absorption of aluminum from aluminum containing antacids (Maalox, Mylanta), potentially increasing aluminum toxicity risk in individuals with kidney impairment. Sodium citrate can decrease the excretion of lithium, potentially leading to lithium toxicity. If you take lithium, monitor serum lithium levels when initiating sodium citrate. Sodium citrate can increase the effects of antihypertensive medications by adding a sodium load that may counteract their blood pressure lowering effects.

Kidney Health: This formulation contains 1,070 to 1,090 mg of sodium per serving. If you have stage 3b, 4, or 5 chronic kidney disease (eGFR below 45 ml per minute), heart failure, or hypertension, this sodium load is potentially dangerous. The kidneys may not be able to excrete the excess sodium, leading to fluid retention, edema, and worsening hypertension. For individuals requiring citrate but needing sodium restriction, potassium citrate is a sodium free alternative. Do not use this formulation without nephrology consultation if you have advanced kidney disease or heart failure.

Metabolic Alkalosis Risk: Excessive sodium citrate intake can cause metabolic alkalosis, characterized by elevated serum bicarbonate (above 32 mEq per liter), hypokalemia (low potassium), and hypocalcemia (low calcium). Symptoms include muscle twitching, tetany, nausea, vomiting, and confusion. Do not exceed the recommended dosage of three servings per day without medical supervision. If you develop symptoms of metabolic alkalosis, discontinue use and consult a healthcare provider.

Pregnancy and Lactation: Sodium citrate is generally recognized as safe during pregnancy and lactation at the doses used for UTI symptom relief (one serving daily). The recommended dosage for pregnancy induced metabolic acidosis (a rare condition) should be determined by a physician. The sodium load is generally well tolerated during pregnancy, but pregnant women with gestational hypertension or preeclampsia should avoid this formulation.

Gastrointestinal: The sodium citrate solution may cause nausea, abdominal cramping, or diarrhea in sensitive individuals, particularly when taken on an empty stomach. If gastrointestinal symptoms occur, take the drink with a small amount of food (a cracker or a few bites of bread). The diarrhea that occasionally occurs with sodium citrate is osmotic in nature and resolves when the dose is reduced or discontinued.

Electrolyte Imbalance: Chronic use of sodium citrate (more than two weeks) can cause hypokalemia (low potassium) because the alkalinization shifts potassium into cells and increases renal potassium excretion. If you require long term alkalinization (for chronic metabolic acidosis or recurrent kidney stones), potassium citrate is preferred over sodium citrate to prevent hypokalemia. If you are using this formulation long term, monitor serum potassium levels periodically.

Dental Considerations: The citric acid in this formulation (both the powdered citric acid and the lemon juice) can erode dental enamel if the drink is held in the mouth or sipped slowly over an extended period. Drink the entire serving quickly, then rinse the mouth with plain water. Do not brush teeth immediately after drinking, as the combination of acid and mechanical abrasion can accelerate enamel erosion. Wait at least 30 minutes before brushing.

Start Slowly: If you are new to sodium citrate or have a history of gastrointestinal sensitivity, begin with half a serving (1.5 grams citric acid, 2 grams sodium bicarbonate, 2.5 ml lemon juice in 100 ml water) for the first one to two doses. Monitor for nausea, cramping, or diarrhea. If no adverse effects occur, increase to the full serving.

---

A Quick Recap of Important Points:

This is not a simple soda water. It is a precision in situ neutralization formulation that converts citric acid and sodium bicarbonate into sodium citrate, a potent urinary alkalinizing agent, through an acid base reaction performed immediately before consumption. The drink delivers approximately 4,000 mg of trisodium citrate containing approximately 1,070 to 1,090 mg of elemental sodium and providing approximately 45 to 50 mEq of alkalizing capacity per serving. The in situ preparation drives off carbon dioxide gas before ingestion, eliminating gastric bloating and belching. For urinary tract infection related irritation, the alkalinized urine (pH 7.0 to 7.5) reduces dysuria, frequency, and urgency within 30 to 60 minutes. For metabolic acidosis in chronic kidney disease, the drink provides base replacement to correct acidosis and slow disease progression. For calcium oxalate kidney stones, the citrate binds urinary calcium, reducing stone formation risk. The sodium load is substantial (1,070 to 1,090 mg per serving) and contraindicated in individuals with hypertension, heart failure, or advanced kidney disease. When taken as directed one to three times daily for short term UTI symptom relief, this drink provides a level of urinary alkalinization that effectively replaces commercial sodium citrate products at a fraction of the cost.

In short, this is an Advanced In Situ Neutralized Sodium Citrate Drink with Urinary Alkalinization, Metabolic Acidosis Correction, and Calcium Binding Activity.

---

The Other Side of the Coin

As with everything in life, good and bad are two sides of a coin. They cannot exist in isolation. So far we have looked only at the bright side. Let us take some time to give some space here to the other side of the coin as well, a space it truly deserves and a disclaimer that can keep us from being too overenthusiastic and blind to possibly negative outcomes based on individual circumstances.

Potential Adverse Reactions by System:

Cardiovascular (Fluid Overload): The sodium load of 1,070 to 1,090 mg per serving can cause fluid retention, worsening hypertension, and exacerbating heart failure. Individuals with baseline hypertension, heart failure with preserved or reduced ejection fraction, or any condition requiring sodium restriction should not use this formulation. Symptoms of fluid overload include weight gain of more than 1 kg in 24 hours, ankle or leg edema, shortness of breath when lying flat, and worsening hypertension.

Metabolic (Alkalosis): Excessive intake causes metabolic alkalosis. Early symptoms include nausea, vomiting, muscle twitching, and hand paresthesias (tingling). Late symptoms include tetany (involuntary muscle contractions), confusion, seizures, and cardiac arrhythmias. If you experience any of these symptoms, discontinue use immediately and seek medical attention.

Gastrointestinal: The high osmolality of the sodium citrate solution (approximately 800 to 1,000 mOsm per liter) causes osmotic diarrhea in approximately 10 to 15 percent of individuals. Nausea and abdominal cramping occur in 15 to 20 percent of new users. Taking the drink with a small amount of food reduces these symptoms but does not eliminate them.

Electrolyte (Hypokalemia): Chronic use (more than two weeks) causes dose dependent hypokalemia. The alkalinization shifts potassium from the extracellular fluid into cells and increases renal potassium excretion. Symptoms include fatigue, muscle weakness, cramping, and cardiac arrhythmias. If you require long term alkalinization, your physician should prescribe potassium citrate instead of sodium citrate.

Renal (Nephrocalcinosis): In individuals with distal renal tubular acidosis who are treated with sodium citrate rather than potassium citrate, the combination of high sodium intake and high calcium excretion can cause nephrocalcinosis (calcium deposition in the kidney parenchyma). This is a theoretical risk with long term use and has been documented in case reports. Potassium citrate does not carry this risk because potassium does not increase calcium excretion.

Drug Interactions Specific: Sodium citrate increases aluminum absorption from aluminum containing antacids. It decreases lithium excretion, potentially causing lithium toxicity. It decreases the blood pressure lowering effect of antihypertensive medications by counteracting their effects with a sodium load. It may increase the risk of digoxin toxicity in the setting of hypokalemia.

The Reaction Completion Test: The completeness of the in situ neutralization reaction can be assessed by the absence of effervescence. When the bubbling and fizzing have completely stopped, the reaction is complete. If you taste the solution and it is sour, unreacted citric acid remains. Add an additional 0.5 grams of sodium bicarbonate, stir, and wait for effervescence to subside. If the solution tastes salty but not sour, and there is no effervescence when stirred, the reaction is complete. If the solution tastes strongly of baking soda (bitter and soapy), excess sodium bicarbonate is present. Add an additional 0.3 grams of citric acid, stir, and wait for effervescence to subside.

Vessel Size Warning: The reaction between 3 grams citric acid and 4 grams sodium bicarbonate in 200 ml water produces approximately 500 to 600 ml of foam. A 300 ml glass will overflow. Use a vessel with a capacity of at least 500 ml, or prepare the mixture in a small bowl or measuring cup and transfer to a drinking glass after the effervescence subsides.

UTI Warning: This drink provides symptomatic relief for UTI related dysuria but does not treat the underlying bacterial infection. If you have symptoms of a urinary tract infection (dysuria, frequency, urgency, hematuria, suprapubic pain, fever, chills), you must see a healthcare provider for antibiotic treatment. Delaying antibiotic treatment while using sodium citrate alone can allow the infection to ascend to the kidneys, causing pyelonephritis. Use this drink only as an adjunct to antibiotics, not as a substitute.

---

Disclaimer: This information is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare provider before making significant changes to your diet or supplement regimen, especially if you have pre existing medical conditions including hypertension, heart failure, chronic kidney disease, renal tubular acidosis, gout, kidney stones, or pregnancy, or if you are taking prescription medications including lithium, aluminum containing antacids, antihypertensives, or digoxin. The in situ neutralization chemistry requires a vessel with adequate capacity to contain the effervescence; failure to use a large enough vessel may result in spillage of the reaction mixture. The sodium load in this formulation is substantial and contraindicated in individuals with conditions requiring sodium restriction. For urinary tract infection symptoms, this drink provides symptomatic relief only and does not treat the underlying infection; you must see a healthcare provider for antibiotics. This formulation is not intended to diagnose, treat, cure, or prevent any disease, including urinary tract infections, metabolic acidosis, or kidney stones. Do not use for more than three consecutive days without medical supervision unless directed by a physician.

--- END ---